Roche

The network will create a nationwide digital infrastructure that enhances diagnostic accuracy while supporting more effective treatment planning for patients throughout Egypt.

The company formalized its commitment with South Korea’s Ministry of Health and Welfare to enhance the bio-healthcare industry by supporting international clinical trials and advancing research for innovative medicines.

The plant is scheduled to begin operations by 2029 and will focus on producing cutting-edge treatments for metabolic conditions, particularly obesity medications.

This oral formulation offers a more convenient delivery method compared to intravenous treatments.